Evidence map

TrialThe Journal of clinical endocrinology and metabolism2015

Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.

Manfredi Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

52 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 25393640